Citius Pharmaceuticals CTXR
NASDAQ CTXR
$0.37 -0.03 (-6.69%)
At close: Oct 22, 2026 · 4:00 PM EDT

Citius Pharmaceuticals (CTXR) Operating Expenses (2010 - 2026)

Updated

Citius Pharmaceuticals (CTXR) posted Operating Expenses of $12.73 million for fiscal Q3 2026 (quarter ended Jun 30, 2026), up 44.9% from $8.79 million a year earlier but down 62.0% from the prior quarter.

Analysis

Citius Pharmaceuticals (CTXR) Operating Expenses (2010 - 2026) Analysis & Trends

For the trailing twelve months through Jun 30, 2026, Operating Expenses at Citius Pharmaceuticals was $66.88 million, up 62.6% year-over-year; for FY2025 (ended Sep 30, 2025), it came in at $38.53 million, down 8.3% from FY2024.

  • Annual Operating Expenses shows a five-year compound annual growth rate of 16.8% (FY2020 to FY2025).
  • In prior fiscal years, Citius Pharmaceuticals' Operating Expenses was $42 million in FY2024 (+14.3%), $36.73 million in FY2023 (+10.3%), $33.32 million in FY2022 (+41.6%) and $23.53 million in FY2021 (+32.9%).
  • Quarterly Operating Expenses has run from a low of $5.2 million in fiscal Q4 2021 to a high of $33.53 million in fiscal Q2 2026 over five years.
  • On a year-over-year basis, Operating Expenses has increased in each of the last three quarters, with growth averaging 30.3% over the last eight quarters.
  • The strongest year-over-year quarter for Operating Expenses in the past five years was fiscal Q2 2026, with growth of 197.8%; the weakest was fiscal Q4 2025, with a decline of 23.6%.
  • According to Business Quant data, Operating Expenses for the three prior fiscal quarters was $33.53 million (Q2 2026), $12.17 million (Q1 2026) and $8.44 million (Q4 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Opex (Qtr)
1 Eli Lilly 1,165.22 Bn 1,133.81 Bn 19.71 Bn 7.95 Bn
2 Johnson & Johnson 646.28 Bn 566.14 Bn 17.30 Bn 11.12 Bn
3 AbbVie 503.17 Bn 476.28 Bn 12.70 Bn 10.56 Bn
4 Merck 365.23 Bn 319.60 Bn 12.21 Bn 12.80 Bn
5 Novartis Ag 302.66 Bn 266.65 Bn 11.24 Bn 6.09 Bn
6 Astrazeneca 267.39 Bn 241.08 Bn 12.86 Bn 9.70 Bn
7 Amgen 241.61 Bn 197.01 Bn 7.24 Bn 6.54 Bn
8 Gilead Sciences 194.67 Bn 168.86 Bn 6.22 Bn 18.20 Bn
9 Pfizer 172.91 Bn 119.55 Bn 10.94 Bn 6.68 Bn
10 Citius Pharmaceuticals 9.70 Mn -23.87 Mn 1.00 Mn 12.73 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 12.73 Mn
Mar 31, 2026 33.53 Mn
Dec 31, 2025 12.17 Mn
Sep 30, 2025 8.44 Mn
Jun 30, 2025 8.79 Mn
Mar 31, 2025 11.26 Mn
Dec 31, 2024 10.04 Mn
Sep 30, 2024 11.05 Mn
Jun 30, 2024 10.63 Mn
Mar 31, 2024 10.97 Mn
Dec 31, 2023 9.34 Mn
Sep 30, 2023 10.12 Mn
Jun 30, 2023 8.67 Mn
Mar 31, 2023 10.69 Mn
Dec 31, 2022 7.25 Mn
Sep 30, 2022 7.55 Mn
Jun 30, 2022 8.92 Mn
Mar 31, 2022 7.59 Mn
Dec 31, 2021 9.26 Mn
Sep 30, 2021 5.20 Mn
API Access

Citius Pharmaceuticals Operating Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=operating-expenses&ticker=CTXR&period=max&api_key=YOUR_API_KEY